1. Preliminary coronavirus vaccine trials show promise  CBS This Morning
  2. Doctor testing Moderna vaccine says it's 'simply mind-boggling' that injection may be ready in 2020  CNBC
  3. A Vaccine With a Poison Pill  Bloomberg
  4. US plans massive COVID-19 vaccine testing effort to meet year-end deadline  CNA
  5. Moderna executives offloaded nearly $30 million of stocks a day after unveiling coronavirus vaccine  Daily Mail
  6. View Full coverage on Google News
Moderna's share price skyrocketed after it released promising results from its vaccine trial Monday, sparking hope that a vaccine could be available January.Moderna's share price skyrocketed after it released promising results from its vaccine trial Monday, sparking hope that a vaccine could be available January.

Moderna executives offloaded nearly $30 million of stocks a day after unveiling coronavirus vaccine | Daily Mail Online

Reuters report on the vaccine trial The US plans a massive round of phase 2 vaccine trials in an effort to speed up the timeline for vaccine development to have a mass candidate ready by year-end. By Adam ButtonReuters report on the vaccine trial The US plans a massive round of phase 2 vaccine trials in an effort to speed up the timeline for vaccine development to have a mass candidate ready by year-end.

US will test vaccines on more than 100,000 people starting in July - report

Bloomberg - Are you a robot?

We may be harder to persuade than we were in the polio vaccine days.We may be harder to persuade than we were in the polio vaccine days.

Column: When we have a coronavirus vaccine, will we want to use it? - Chicago Tribune

The speed in developing vaccines for widespread testing this summer is impressive, but running trials involving tens of thousands of people will be an immense undertaking.The speed in developing vaccines so far is impressive, but running trials this summer involving tens of thousands of people will be a tough challenge.

Op-Ed: Fast coronavirus vaccine could bring problems - Los Angeles Times

Will vaccine for COVID-19 play into the developing narrative of seeing a shift of technological and scientific innovation from the Global North to the Global South? Or will the race simply re-instate the Cold War notion of Western world dominance?Will COVID vaccine shift narrative in technological & scientific innovation from Global North to Global South? 

Will India Overtake China As Global Power If It Wins the Vaccine Race? | OPINION

If there is a silver lining to the flawed U.S. response to the coronavirus pandemic, it is this: The relatively high number of new cases being diagnosed daily — upward of 20,000 — will make it easier to test new vaccines.If there is a silver lining to the flawed U.S. response to the coronavirus pandemic, it is this: The relatively high number of new cases being diagnosed daily — upward of 20,000 — will make it easier to test new vaccines.

Analysis: Get ready for the vaccine — they’re never simple

“The U.S. government is providing billions to the drug companies to develop a COVID-19 vaccine. Once that vaccine is approved by the FDA, it must be available to all for free. We've already paid for it. This is not a time for pharmaceutical industry profiteering.”

Bernie Sanders on Twitter: "The U.S. government is providing billions to the drug companies to develop a COVID-19 vaccine. Once that vaccine is approved by the FDA, it must be available to all for free. We've already paid for it. This is not a time for pharmaceutical industry profiteering."

“Worth reading on covid vaccines: be ready for something more like a flu vaccine, than the smallpox one. (But we mustn't let the perfect be the enemy of the good) https://t.co/zeIYtFifK4 via @statnews”

Evan Davis on Twitter: "Worth reading on covid vaccines: be ready for something more like a flu vaccine, than the smallpox one. (But we mustn't let the perfect be the enemy of the good) https://t.co/zeIYtFifK4 via @statnews"

“This is what our government is paying to develop a COVID19 vaccine: - $1.2 billion to AstraZeneca - $483 million to Moderna - $500 million to Johnson & Johnson - $30 million to Sanofi Once a vaccine is approved by the FDA, it must be available to all for free. No profiteering.”

Bernie Sanders on Twitter: "This is what our government is paying to develop a COVID19 vaccine: - $1.2 billion to AstraZeneca - $483 million to Moderna - $500 million to Johnson & Johnson - $30 million to Sanofi Once a vaccine is approved by the FDA, it must be available to all for free. No profiteering."

“5 articles I wrote on the economic lessons from COVID19 On State Capacity https://t.co/TVrNR0z16o Doing Capitalism Differently https://t.co/EQ311xv0bm Triple Crisis https://t.co/fsrO2ReuHR) A Vaccine for All https://t.co/O6nY5pu2g1 Big Pharma Must Change https://t.co/Rrp7UibdyS”

Mariana Mazzucato on Twitter: "5 articles I wrote on the economic lessons from COVID19 On State Capacity https://t.co/TVrNR0z16o Doing Capitalism Differently https://t.co/EQ311xv0bm Triple Crisis https://t.co/fsrO2ReuHR) A Vaccine for All https://t.co/O6nY5pu2g1 Big Pharma Must Change https://t.co/Rrp7UibdyS"

Skeptics are questioning the biotech's recent coronavirus vaccine-related announcements.Skeptics are questioning the biotech's recent coronavirus vaccine-related announcements.

Why Moderna Stock Dropped Thursday | The Motley Fool

The United States plans a massive testing effort involving more than 100,000 volunteers and a half dozen or so of the most promising vaccine ...The United States plans a massive testing effort involving more than 100,000 volunteers and a half dozen or so of the most promising vaccine ...

US plans massive COVID-19 vaccine testing effort to meet year-end deadline - CNA

In a recent poll by Reuters and Ipsos, 1 out of 4 of Americans had little or no interest in a COVID-19 vaccine. Fears stem from 'Operation Warp Speed' sacrificing safety for speed. 'Many experts believe a fully tested, government-approved vaccine will not be widely available until mid-2021 at the earliest.'

Americans express fears surrounding a COVID-19 vaccine | World Economic Forum

News, analysis and comment from the Financial Times, the worldʼs leading global business publication

Subscribe to read | Financial Times

Vaccine developers have four major strategies in their efforts to make a coronavirus vaccine: gene-based, adenovirus vectors, inactivated, and protein subunit. All have pros and cons, both around how they provide protection from a virus and how they’re manufactured.There are other options if they don’t work.

Unproven strategies lead the race for a COVID-19 vaccine - The Verge

The United States plans a massive testing effort involving more than 100,000 volunteers and a half dozen or so of the most promising vaccine candidates in an effort to deliver a safe and effective one by the end of 2020, scientists leading the program told Reuters.The United States plans a massive testing effort involving more than 100,000 volunteers and a half dozen or so of the most promising vaccine candidates in an effort to deliver a safe and effective one by the end of 2020, scientists leading the program told Reuters.

Vincent Chen wrote that it was “hard to pick winners” among the many Covid-19 vaccine programs, and that a vaccine wouldn’t be widely available until later next year.Vincent Chen wrote that it was “hard to pick winners” among the many Covid-19 vaccine programs, and that a vaccine wouldn’t be widely available until later next year.

A Covid-19 Vaccine Could Be Ready Late This Year, Bernstein Analyst Says - Barron's

Operation Warp Speed's funding of AstraZeneca is intended to deliver a COVID-19 vaccine by October, although some call that timeline unrealistic.Operation Warp Speed's funding of AstraZeneca is intended to deliver a COVID-19 vaccine by October, although some call that timeline unrealistic.

Doubts greet $1.2 billion bet by United States on a coronavirus vaccine by October | Science | AAAS

Early progress has been reported on several vaccine efforts, as scientists around the world scramble to test ways to protect people from the coronavirus.Early progress has been reported on several vaccine efforts, as scientists around the world scramble to test ways to protect people from the coronavirus.

1/VACCINE RACE1/VACCINE RACE

Take Five: Coronavirus vaccine race is on - Reuters

Dr. Anthony Fauci said that he's "cautiously optimistic" about the coronavirus vaccine Moderna is working on. The National Institute of Allergy and Infectious Diseases (NIAID) is one of Moderna's partners on the COVID-19 drug, but the agency has been quiet this week on the heels of Moderna's ...Dr. Anthony Fauci said that he’s “cautiously optimistic” about the coronavirus vaccine Moderna is working on. The National Institute of Allergy and Infectious Diseases (NIAID) is …

Dr. Fauci has some good news about a coronavirus vaccine – BGR

Biotech stocks are in the spotlight in 2020, with the race to develop testing, treatment and a vaccine for Covid-19 driving rapid growth.Biotech stocks are in the spotlight in 2020, with the race to develop testing, treatment and a vaccine for Covid-19 driving rapid growth.

7 Top-Rated Biotech Stocks to Buy on the Hunt for a Vaccine | InvestorPlace

The firm says its experimental mRNA vaccine is safe and induced promising levels of antibodies in a small Phase I clinical trial

Moderna provides cursory glance at first COVID-19 vaccine data

As the coronavirus (COVID-19) pandemic continues ravaging the globe, the search for a vaccine against the novel infectious disease has become the primary concern for...As the coronavirus (COVID-19) pandemic continues ravaging the globe, the search for a vaccine against the novel infectious disease has become the primary concern for...

US Top Health Expert Fauci Explains Risks Behind Development of COVID-19 Vaccine - Sputnik International

Early morning on May 18, Moderna, a biotechnology company, revealed the preliminary findings for the much anticipated phase I trial of an mRNA COVID-19 vaccine. The information sent Moderna’s stock soaring by more than 20% and helped fuel a rally on…Early morning on May 18, Moderna, a biotechnology company, revealed the preliminary findings for the much anticipated phase I trial of an mRNA COVID-19 vaccine. The information sent Moderna’s stock soaring by more than 20% and helped fuel a rally on…

The first coronavirus vaccine trial was "promising," but what does that really mean?

Four of the biotech's top executives netted a total of $30 million since positive results for a coronavirus vaccine were touted.Four of the biotech's top executives netted a total of $30 million since positive results for a coronavirus vaccine were touted.

Moderna CEO and other execs made millions on vaccine announcement - CBS News

404 Not Found

NoCookies | The Australian

Access Denied

A coronavirus vaccine might be the door out of this hell. What if our neighbors refuse to walk through it?As the COVID-19 pandemic has unwound around the world and in North Texas, there's been a pot of gold at the end of the rainbow. The only surefire way out of our new confines, according to epidemiologists and public health officials, is researchers finding a vaccine for the novel coronavirus...

What If Texans Won't Get a Coronavirus Vaccine? | Dallas Observer

Almost 20% of people surveyed by YouGov said they wouldn't be willing to be vaccinated against coronavirus.Almost 20% of people surveyed by YouGov said they wouldn't be willing to be vaccinated against coronavirus.

Coronavirus vaccine: Only 55% of Americans would get immunized, survey - Business Insider

A new poll from Reuters and Ipsos has found that a quarter of Americans weren't interested in taking a Covid-19 vaccine, which doesn't even exist.Covid-19 has wreaked havoc on the world, causing 5 million recorded infections and 333,000 deaths so far, with a third of the world under lockdown. In orde

A Quarter Of Americans Are Hesitant About Taking A Covid-19 Vaccine That Doesn't Yet Exist | IFLScience

A New Zealand company says it's early days, but it's cautiously optimistic about its chances of developing a Covid-19 vaccine.A New Zealand company says it's early days, but it's cautiously optimistic about its chances of developing a Covid-19 vaccine.

FoxNews.com

404 | Fox News

The nation's top infectious disease expert said Friday that an aggressive investment into the development and production of a vaccine against the coronavirus might make it possible to distribute millions of doses as the year comes to a close.The nation's top infectious disease expert said Friday that an aggressive investment into the development and production of a vaccine against the coronavirus might make it possible to distribute

The Hill interview: Fauci on why a vaccine by end of year is 'aspirational' | TheHill

The nation's top infectious disease expert said Friday that an aggressive investment into the development and production of a vaccine against the coronavirus might make it possible to distribute millions of doses as the year comes to a close.The nation's top infectious disease expert said Friday that an aggressive investment into the development and production of a vaccine against the coronavirus might make it possible to distribute

The Hill interview: Fauci on why a vaccine by end of year is 'aspirational' | TheHill

It feels like our only hope against coronavirus, so...when will a COVID-19 vaccine be ready? Experts explain the development timeline from start to finish.Be prepared for a long wait.

When will a COVID-19 vaccine be ready? Be ready to wait | Well+Good

Hydroxychloroquine linked to increased death in COVID-19 patients | Fauci says it’s ‘conceivable’ that US could have vaccine by December | Biden says he would make a coronavirus vaccine free to everyone in the country | The virus’s strangest symptoms are just emerging | On Memorial Day weekend, neighboring beach towns tell New Yorkers to stay away | Will the pandemic foreverHydroxychloroquine linked to increased death in COVID-19 patients | Fauci says it’s ‘conceivable’ that US could have vaccine by December | Biden says he would make a coronavirus vaccine free to

The Hill's Coronavirus Report: Surgeon General stresses need to invest much more in public health infrastructure, during and after COVID-19; Fauci hopeful vaccine could be deployed in December | TheHill

Hydroxychloroquine linked to increased death in COVID-19 patients | Fauci says it’s ‘conceivable’ that US could have vaccine by December | Biden says he would make a coronavirus vaccine free to everyone in the country | The virus’s strangest symptoms are just emerging | On Memorial Day weekend, neighboring beach towns tell New Yorkers to stay away | Will the pandemic foreverHydroxychloroquine linked to increased death in COVID-19 patients | Fauci says it’s ‘conceivable’ that US could have vaccine by December | Biden says he would make a coronavirus vaccine free to

The Hill's Coronavirus Report: Surgeon General stresses need to invest much more in public health infrastructure, during and after COVID-19; Fauci hopeful vaccine could be deployed in December | TheHill

In this week’s interview, Dr. Peter Hotez discusses his alarm that the Houston area doesn’t yet have the public-health troops it needs to reopen, his worries about the anti-vaccine movement, and a surprising new funder of his research — Tito’s Vodka. <p>In this week’s interview, Dr. Peter Hotez discusses his alarm that the Houston area doesn’t yet have the public-health troops it needs to reopen, his worries about the anti-vaccine movement, and a surprising new funder of his research — Tito’s Vodka.</p>

Vaccine expert Peter Hotez reveals 3 things to help Houston reopen, avoid second surge of COVID-19 - HoustonChronicle.com

For all The Spinoff’s latest coverage of Covid-19 see here. Read Siouxsie Wiles’s work here. New Zealand is currently in alert level two – read The Spinoff’s giant explainer about what that means here. For official government advice, see here. The Spinoff’s coverage of the Covid-19 outbreak is fuFor all The Spinoff’s latest coverage of Covid-19 see here. Read Siouxsie Wiles’s work here. New Zealand is currently in alert level two – read The Spinoff’s giant explainer about what that means here. For official government advice, see here. The Spinoff’s coverage of the Covid-19 outbreak is fu

Covid-19 live updates, May 23: No new cases; NZ company to start working on vaccine | The Spinoff

Pending the results of a Phase III efficacy trial this summer, a vaccine produced by the biotech company Moderna could be ready for approval as soon as the fall.Pending the results of a Phase III efficacy trial this summer, a vaccine produced by the biotech company Moderna could be ready for approval as soon as the fall.

The Coronavirus Vaccine Is on Track to Be the Fastest Ever Developed | The New Yorker

About 2.4 million Americans filed for unemployment last week. And we're in for an extremely active hurricane season. It's Thursday's news.About 2.4 million Americans filed for unemployment last week. And we're in for an extremely active hurricane season. It's Thursday's news.

Coronavirus, vaccine, Michigan flooding, Ford, unemployment: Thursday's news

The following is a brief roundup of some of the latest scientific studies on the novel coronavirus and efforts to find treatments and vaccines for COVID-19, the illness caused by the virus.The following is a brief roundup of some of the latest scientific studies on the novel coronavirus and efforts to find treatments and vaccines for COVID-19, the illness caused by the virus.

Coronavirus vaccine safe in early trial, hydroxychloroquine may increase death risk

Vaccines will be tested in healthcare workers and communities where the virus is still spreading to show whether they reduced new cases of Covid-19.Vaccines will be tested in healthcare workers and communities where the virus is still spreading to show whether they reduced new cases of Covid-19.

Covid-19: US plans massive coronavirus vaccine testing effort to meet year-end deadline - News | Khaleej Times